Hunter syndrome (Mucopolysaccharidosis type II), severe phenotype: Long term follow-up on patients undergone to hematopoietic stem cell transplantation

Minerva Pediatrica

Volumn 65, Issue 5, 2013, Pages 487-496

  Annibali, R ^a   Caponi, L ^a   Morganti, A ^a   Manna, M ^a   Gabrielli, O ^a   Ficcadenti, A ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Central nervous system; Hematopoietic stem cell transplantation; Magnetic resonance imaging; Mucopolysaccharidoses

Indexed keywords

CHONDROITIN SULFATE; CREATININE; DERMATAN SULFATE; ENZYME; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; IDURONATE 2 SULPHATASE ENZYME; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CHILD; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CREATININE BLOOD LEVEL; DELTA RHYTHM; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROENCEPHALOGRAM; ENGRAFTMENT; ENZYME ACTIVITY; EVOKED BRAIN STEM AUDITORY RESPONSE; FACIES; FOLLOW UP; HEAD CIRCUMFERENCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; HUNTER SYNDROME; HURLER SYNDROME; HYPERTROPHY; INTELLIGENCE QUOTIENT; JOINT STIFFNESS; LANGUAGE DELAY; LIVER BIOPSY; LONG TERM CARE; MALE; MENTAL DEFICIENCY; MITRAL VALVE DISEASE; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION DEAFNESS; PHENOTYPE; PRESCHOOL CHILD; SKELETON RADIOGRAPHY; SKIN BIOPSY; SPLENOMEGALY; THETA RHYTHM; UMBILICAL HERNIA; URINALYSIS; URINARY EXCRETION; URINE SEDIMENT; WHITE MATTER LESION;

CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MUCOPOLYSACCHARIDOSIS II; PHENOTYPE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84887075747     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bergstrom SK, Quinn JJ, Greenstein R, Ascensao J. Long-term follow up of a patient transplanted for Hunter's disease type IIB: a case report and literature review. Bone Marrow Transplant 1994; 14.653-8.
2. Bruni S, Loschi S, Incerti C, Gabrielli O, Coppa GV. Update on treatment of lysosomal storage diseases. Acta Myol 2007;26:87-92. (Pubitemid 47400735)
3. Coppa GV, Gabrielli O, Zampini L, Pierani P. Bone marrow transplantation in Hunter Sindrome (Mucopolysaccharidosis type II): two years follow-up of the first italian patient and review of the literature. Pediatria Medica Chirurgica 1995;17:227-35.
4. Finn CT, Vedolin L, Schwartz IV, Giugliani R, Haws CA, Prescot AP et al. Magnetic resonance imaging findings in Hunter syndrome. Acta Paediatr Suppl 2008;97:61-8. (Pubitemid 351421289)
5. Froissart R, Da Silva IM, Maire I. Mucopolysaccaridosis type 2: an update on mutation spectrum. Acta Paediatrica 2007;90:71-7. (Pubitemid 46481123)
6. Gabrielli O, Polonara G, Regnicolo L, Petroni L, Scarabino T, Coppa GV, Salvolini U. Correlation between cerebral MRI abnormalities and mental retardation in patient with mucopolysaccharidoses. American Journal of Medical Genetics 2004;125A:224-31. (Pubitemid 38294839)
7. Guffon N, Bertrand Y, Forest I, Fouilhoux A, Froissart R. Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years. The Journal of Pediatrics 2009;154:733-7.
8. Hoffmann B, Schulze-Frenking G, Al-Sawaf S, Beck M, Mayatepek E. Hunter disease before and during enzyme replacement therapy. Pediatr Neurol 2011;45:181-4.
9. Krivit W. Stem cell bone marrow transplantation in patients with metabolic storage diseases. Advances in Pediatrics 2002;49:359-78.
10. Krivit W. Allogenic stem cells transplantation for the treatment of lysosomal and peroxisomal metabolic disease. Springer Semin Immunopathol 2004;26:119-32. (Pubitemid 40021961)
11. Manara R, Priante E, Grimaldi M. Brain and spine MRI feature of Hunter disease: frequency, natural evolution and response to therapy. Journal Of Inherited Metabolic Disease 04/2011.
12. McKinnis EJ, Sulzbacher S, Rutledge JC. Bone marrow transplantation in Hunter syndrome. Journal of Pediatrics 1996;129:145-8. (Pubitemid 26277259)
13. Muenzer J, Bodamer O, Burton B, Clarke L, Frenking GS, Giugliani R et al. The role of enzyme replacement therapy in severe Hunter syndrome - An expert panel consensus. Eur J Pediatr 2012;171:181-8.
14. Peters C, Krivit W. Hematopoietic cell transplantation for Mucopolysaccharidosis type 2 (Hunter Syndrome). Bone Marrow Transplant 2000;25:1097-9.
15. Piotrowska E, Jakobkiewicz-Banecka J, Tylki-Szymanska A, Czartoryska B, Wegrzyn A, Wegrzyn G. Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and efficiency of glycosaminoglycan synthesis. Acta Paediatrica 2009;98:743-9.
16. Scarpa M, Almassy Z, Beck M. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet Journal of Rare Disease 2011;6:72 (Open Access Review).
17. Tylki-Szymanska A, Jurecka A, Zuber A, Rozdzynska A, Marucha J, Czartoryska B. Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up. Acta Paediatr 2012;101:e42-7.
18. McKinnis FJ, Sulzbacher S, Rutledge JC, Sanders J, Scott CR. Bone marrow transplantation in Hunter syndrome. J Pediatr 1996;129:145-8. (Pubitemid 26277259)
19. Muenzer J, Beck M, Eng CM, Escolar ML. Multidisciplinary management of Hunter syndrome. Pediatrics 2009;124:e1228-e39.
20. Vellodi A, Young E, Cooper A, Lidchi V, Winchester B, Wraith JE.Long-term follow-up following bone marrow transplantation for Hunter syndrome. J Inhetit Metab Dis 1999;22:638-648. (Pubitemid 29278276)
21. Winchester B, Vellodi A, Young E. The molecular basis of lysosomal storage diseases and their treatment. Biochemical Society Transactions 2000;28:150-4. (Pubitemid 30103231)
22. Wraith JE. Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II. Acta Paediatrica 2008, volume 97, issue supplement s457:76-78.
23. Wraith JE, Scarpa M, Beck M et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 2008;167:267-77.
24. Young ID, Harper PS. The natural history of the severe form of Hunter's syndrome: a study based on 52 cases. Dev Med Child Neurol 1983;25:481-9. (Pubitemid 13030892)
25. Young ID, Harper PS, Newcombe RG, Archer IM. A clinical and genetic study of Hunter's syndrome. Differences between the mild and severe forms. J Med Genet 1982;19:408-11. (Pubitemid 13167537)